Anpario (LON:ANP) Price Target Raised to GBX 550

Key Points

• Analysts at Canaccord Genuity Group have raised Anpario's price target from GBX 500 to GBX 550, indicating a potential upside of 18.34% from the current price.
• Anpario has received a consensus rating of "Buy" from research analysts, with Shore Capital reaffirming a "house stock" rating on the company.
• The company's latest quarterly earnings report indicated an EPS of GBX 16.87 and a net margin of 9.23%, reflecting solid financial performance.

Anpario (LON:ANP - Get Free Report) had its price target upped by analysts at Canaccord Genuity Group from GBX 500 to GBX 550 in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage presently has a "buy" rating on the stock. Canaccord Genuity Group's price objective points to a potential upside of 18.34% from the stock's current price.

Separately, Shore Capital reiterated a "house stock" rating on shares of Anpario in a research note on Tuesday, September 23rd. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Anpario currently has a consensus rating of "Buy" and a consensus price target of GBX 550.

Anpario Stock Up 1.0%

ANP stock opened at GBX 464.75 on Tuesday. Anpario has a twelve month low of GBX 286 and a twelve month high of GBX 520. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10. The firm has a market cap of £78.76 million, a PE ratio of 15.64 and a beta of 0.58. The business has a 50 day moving average of GBX 457.76 and a 200 day moving average of GBX 427.91.

Anpario (LON:ANP - Get Free Report) last posted its quarterly earnings data on Wednesday, September 10th. The company reported GBX 16.87 earnings per share for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. On average, research analysts forecast that Anpario will post 23.5757801 EPS for the current fiscal year.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.